UPDATE: This event has been postponed until 2021.
The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market.
The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market.
By signing up, you’re agreeing to receive email from SCB. But rest assured: we respect your privacy.